NZ198435A - Pharmaceutical compositions containing a salt of 1-(2,3,4-trimethoxybenzyl)piperazine - Google Patents

Pharmaceutical compositions containing a salt of 1-(2,3,4-trimethoxybenzyl)piperazine

Info

Publication number
NZ198435A
NZ198435A NZ198435A NZ19843581A NZ198435A NZ 198435 A NZ198435 A NZ 198435A NZ 198435 A NZ198435 A NZ 198435A NZ 19843581 A NZ19843581 A NZ 19843581A NZ 198435 A NZ198435 A NZ 198435A
Authority
NZ
New Zealand
Prior art keywords
trimethoxybenzyl
piperazine
salt
dosage unit
pharmaceutical preparation
Prior art date
Application number
NZ198435A
Other languages
English (en)
Inventor
J C Arnaud
M Devissaguet
Original Assignee
Science Union & Cie
Medicale Rech France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9246419&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NZ198435(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Science Union & Cie, Medicale Rech France filed Critical Science Union & Cie
Publication of NZ198435A publication Critical patent/NZ198435A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NZ198435A 1980-09-30 1981-09-22 Pharmaceutical compositions containing a salt of 1-(2,3,4-trimethoxybenzyl)piperazine NZ198435A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8020919A FR2490963B1 (fr) 1980-09-30 1980-09-30 Nouvelle composition therapeutique a action anti-ischemique contenant de la trimethoxy 2, 3, 4-benzyl 1-piperazine

Publications (1)

Publication Number Publication Date
NZ198435A true NZ198435A (en) 1984-02-03

Family

ID=9246419

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ198435A NZ198435A (en) 1980-09-30 1981-09-22 Pharmaceutical compositions containing a salt of 1-(2,3,4-trimethoxybenzyl)piperazine

Country Status (14)

Country Link
US (1) US4407801A (cg-RX-API-DMAC7.html)
AU (1) AU550761B2 (cg-RX-API-DMAC7.html)
BE (1) BE890568A (cg-RX-API-DMAC7.html)
CA (1) CA1169775A (cg-RX-API-DMAC7.html)
CH (1) CH650675A5 (cg-RX-API-DMAC7.html)
DE (1) DE3139005A1 (cg-RX-API-DMAC7.html)
FR (1) FR2490963B1 (cg-RX-API-DMAC7.html)
GB (1) GB2084019B (cg-RX-API-DMAC7.html)
GR (1) GR75803B (cg-RX-API-DMAC7.html)
IE (1) IE51764B1 (cg-RX-API-DMAC7.html)
IT (1) IT1171557B (cg-RX-API-DMAC7.html)
LU (1) LU83654A1 (cg-RX-API-DMAC7.html)
NZ (1) NZ198435A (cg-RX-API-DMAC7.html)
ZA (1) ZA816766B (cg-RX-API-DMAC7.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4448776A (en) * 1981-02-12 1984-05-15 Karl Bucher Method of using certain substituted aliphatic secondary amines or their salts for easing breathing
SE8403912D0 (sv) * 1984-07-30 1984-07-30 Pharmacia Ab Lekemedelssats eller -komposition
FR2717687B1 (fr) * 1994-03-24 1996-06-14 Adir Compositions pharmaceutiques permettant la libération prolongée de trimétazidine après administration par voie orale.
EP1104673A1 (en) * 1999-11-30 2001-06-06 Bayer Classics A hydrogen carbonate-containing, desintegrating agent-free pharmaceutical composition
FR2802424B1 (fr) * 1999-12-17 2002-02-15 Adir Comprime matriciel permettant la liberation prolongee de trimetazidine apres administration par voie orale
FR2805463B1 (fr) * 2000-02-25 2003-01-24 Adir UTILISATION DE LA TRIMETAZIDINE POUR L'OBTENTION DE COMPOSITIONS PHARMACEUTIQUES DESTINEES A INHIBER L'ACYL-CoA ACETYLTRANSFERASE
FR2818549B1 (fr) * 2000-12-26 2003-02-07 Servier Lab Composition pharmaceutique solide thermoformable pour la liberation controlee de trimetazidine
WO2007116243A2 (en) * 2006-04-10 2007-10-18 Mintails Limited Method for treating fibromyalgia and related conditions
EA009776B1 (ru) * 2006-07-18 2008-04-28 Мераб Ревазович Кокеладзе Способ изготовления таблетированной лекарственной формы триметазидина дигидрохлорида и ее состав
FR2986431B1 (fr) * 2012-02-03 2017-03-17 Servier Lab Composition pharmaceutique a liberation prolongee de trimetazidine, son procede de fabrication et son utilisation dans des traitements therapeutiques
US8920855B1 (en) 2012-10-30 2014-12-30 Setem Hemth, Inc Methods of topically treating tinnitus and related disorders
CN105055352A (zh) * 2015-08-11 2015-11-18 瑞阳制药有限公司 盐酸曲美他嗪片及其制备方法
US11123345B2 (en) * 2016-11-21 2021-09-21 Saghmos Therapeutics, Inc. Prevention and/or treatment of contrast-induced acute kidney injury
CN107982231B (zh) * 2018-01-03 2021-05-07 江苏吴中医药集团有限公司 一种盐酸曲美他嗪片及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3262852A (en) * 1966-07-26 Vasodilator and anti-anginose com- pounds containing methoxy benzyl piperazines and method of using the same
FR805M (cg-RX-API-DMAC7.html) * 1960-06-30 1961-09-01

Also Published As

Publication number Publication date
CH650675A5 (fr) 1985-08-15
IT8149377A1 (it) 1983-03-28
CA1169775A (fr) 1984-06-26
FR2490963A1 (fr) 1982-04-02
BE890568A (fr) 1982-03-30
GB2084019B (en) 1984-09-12
IE812256L (en) 1982-03-30
IE51764B1 (en) 1987-03-18
IT1171557B (it) 1987-06-10
GB2084019A (en) 1982-04-07
ZA816766B (en) 1982-09-29
DE3139005A1 (de) 1982-05-06
FR2490963B1 (fr) 1986-04-18
IT8149377A0 (it) 1981-09-28
AU7574481A (en) 1982-04-08
LU83654A1 (fr) 1982-04-14
AU550761B2 (en) 1986-04-10
GR75803B (cg-RX-API-DMAC7.html) 1984-08-02
US4407801A (en) 1983-10-04

Similar Documents

Publication Publication Date Title
US4981871A (en) Treatment of ocular hypertension with class I calcium channel blocking agents
ES2386786T3 (es) Método para tratar rubor cutáneo usando agonistas selectivos de receptores alpha-2-adrenérgicos.
US4407801A (en) Anti-ischemic pharmaceutic compositions
DE69934305T2 (de) Verwendung von dexmedetomidine zur sedierung auf der intensivstation
Lai Adverse effect of intraoperative phenylephrine 10%: case report.
Schoenfeld et al. Retinal hemorrhages in the newborn following labor induced by oxytocin or dinoprostone
US6462066B2 (en) Method and composition for treatment of ischemic neuronal reperfusion injury
EP0887078A1 (en) Use of L or DL-threo-DOPS for preventing and treating the consequences of cerebral ischemia
EP1513533A2 (de) Pharmazeutische wirkstoffkombination sowie deren verwendung
CN102028694A (zh) 法舒地尔经眼部给药用于制备治疗青光眼药物中的应用
Hoagland et al. Antihistaminic drugs for colds: evaluation based on a controlled study
LEIBOLD Drugs having a toxic effect on the optic nerve
US20190224208A1 (en) Pharmaceutical composition for treating premature ejaculation and method for treating premature ejaculation
CN116585447A (zh) 脑卒中联合用药物及其应用
JP2610619B2 (ja) 高眼圧症治療用点眼剤
EP3731836B1 (en) Beta-blockers for treating and/or preventing pathological scars
RU2481124C1 (ru) Фармацевтическая комбинация из аторвастатина и ницерголина для профилактики или лечения нарушений мозгового кровообращения
JP2004331502A (ja) 視神経細胞保護剤
JPS59139319A (ja) 脳障害による身体機能障害治療剤
JP2005521681A (ja) 尿素および尿素誘導体を使用した眼科疾患の治療方法
JPH11292764A (ja) グルタミン酸類が関与する疾患の治療および／または予防薬
Moore 8 Chapter Anticholinergic Agents (Parasympatholytics)
Christensen Bradycardia as a side‐effect to oxybuprocaine
Kiseleva et al. Phezam Research. Phezam-reliable protection of the brain
Sampaolesi et al. Medical Therapy in Glaucoma